Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(3-(4-((2,6-dimethylmorpholino)methyl)styryl)-1h-indazol-6-yl)-5'-methoxyspiro(cyclopropane-1,3'-indolin)-2'-one
2. Cfi-400945
1. Cfi-400945
2. 1338806-73-7
3. Cfi-400945 (free Base)
4. Tl1ud860aa
5. 1338806-76-0
6. 1616420-30-4
7. (2's,3r)-2'-[3-[(e)-2-[4-[[(2r,6s)-2,6-dimethylmorpholin-4-yl]methyl]phenyl]ethenyl]-1h-indazol-6-yl]-5-methoxyspiro[1h-indole-3,1'-cyclopropane]-2-one
8. Cfi400945
9. (2's,3r)-2'-[3-[(e)-2-[4-[[(2s,6r)-2,6-dimethylmorpholin-4-yl]methyl]phenyl]ethenyl]-1h-indazol-6-yl]-5-methoxyspiro[1h-indole-3,1'-cyclopropane]-2-one
10. Spiro(cyclopropane-1,3'-(3h)indol)-2'(1'h)-one, 2-(3-((1e)-2-(4-(((2r,6s)-2,6-dimethyl-4-morpholinyl)methyl)phenyl)ethenyl)-1h-indazol-6-yl)-5'-methoxy-, (1r,2s)-
11. Ocifisertib
12. Unii-tl1ud860aa
13. Schembl9946383
14. Gtpl12083
15. Ex-a1609
16. Nsc791966
17. S7552
18. Zinc145048061
19. Ccg-269938
20. Cs-5939
21. Nsc-791966
22. Sb17032
23. Cfi-400945,
24. Ac-36327
25. As-35185
26. Hy-12300
27. A935188
28. (1r,2s)-2-(3-((e)-4-(((2r,6s)-2,6-dimethyl Morpholino)methyl)styryl)-1h-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one
29. (1r,2s)-2-(3-((e)-4-(((2r,6s)-2,6-dimethylmorpholino)methyl)styryl)-1h-indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one
| Molecular Weight | 534.6 g/mol |
|---|---|
| Molecular Formula | C33H34N4O3 |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 534.26309096 g/mol |
| Monoisotopic Mass | 534.26309096 g/mol |
| Topological Polar Surface Area | 79.5 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 942 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
18
PharmaCompass offers a list of CFI-400945 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CFI-400945 manufacturer or CFI-400945 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CFI-400945 manufacturer or CFI-400945 supplier.
PharmaCompass also assists you with knowing the CFI-400945 API Price utilized in the formulation of products. CFI-400945 API Price is not always fixed or binding as the CFI-400945 Price is obtained through a variety of data sources. The CFI-400945 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CFI-400945 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CFI-400945, including repackagers and relabelers. The FDA regulates CFI-400945 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CFI-400945 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CFI-400945 supplier is an individual or a company that provides CFI-400945 active pharmaceutical ingredient (API) or CFI-400945 finished formulations upon request. The CFI-400945 suppliers may include CFI-400945 API manufacturers, exporters, distributors and traders.
CFI-400945 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CFI-400945 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CFI-400945 GMP manufacturer or CFI-400945 GMP API supplier for your needs.
A CFI-400945 CoA (Certificate of Analysis) is a formal document that attests to CFI-400945's compliance with CFI-400945 specifications and serves as a tool for batch-level quality control.
CFI-400945 CoA mostly includes findings from lab analyses of a specific batch. For each CFI-400945 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CFI-400945 may be tested according to a variety of international standards, such as European Pharmacopoeia (CFI-400945 EP), CFI-400945 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CFI-400945 USP).
